tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
INmune Bio downgraded to Neutral from Buy at BTIG
PremiumThe FlyINmune Bio downgraded to Neutral from Buy at BTIG
18d ago
Inmune Bio’s Xpro Alzheimer’s Trial Faces Challenges, Justifying Hold Rating
Premium
Ratings
Inmune Bio’s Xpro Alzheimer’s Trial Faces Challenges, Justifying Hold Rating
18d ago
Inmune Bio Secures $18.9 Million in Stock Offering
Premium
Company Announcements
Inmune Bio Secures $18.9 Million in Stock Offering
18d ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
18d ago
INmune Bio reports findings from Phase 2 MINDFuL trial of XPro
Premium
The Fly
INmune Bio reports findings from Phase 2 MINDFuL trial of XPro
18d ago
Biotech INmune BIO (INMB) Collapses 60% after Alzheimer’s Trial Misses Goals
Premium
Market News
Biotech INmune BIO (INMB) Collapses 60% after Alzheimer’s Trial Misses Goals
19d ago
INmune Bio announces $19M registered direct offering priced at-the-market
PremiumThe FlyINmune Bio announces $19M registered direct offering priced at-the-market
21d ago
Unusually active option classes on open June 27th
Premium
The Fly
Unusually active option classes on open June 27th
22d ago
Inmune Bio to Present Phase 2 Trial Data
Premium
Company Announcements
Inmune Bio to Present Phase 2 Trial Data
22d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100